Brief: AnaptysBio Q4 Net Income USD -42.211 Million
11/03/2024 20:15
Mar 11 (Reuters) - AnaptysBio Q4 income from operations USD -42.135 million. * Q4 operating expenses USD 51.14 million * Q4 collaboration revenue USD 9.005 million
Recent news on AnaptysBio
See all newsU.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
AnaptysBio's Q1 collaboration revenue falls, net loss widens
Brief: AnaptysBio Q1 Net Income USD -52.884 Million
Brief: Anaptys Appoints Chris Murphy As Chief Financial Officer And Owen Hughes To Board Of Directors
Brief: GSK Says Unit Tesaro's Claim For Declaratory Judgment Against Anaptysbio Unchanged